US5124145A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for the prevention and treatment of bovine mastitis
Assignee: Novartis Corp
•
Filing: 1989-10-24
•
Granted: 1992-06-23
•
Expires: 2009-10-24
Abstract
Abstract A method for treating or preventing mastitis in cows is disclosed. The method contemplates the intramammary injection of bovine interferon-gamma. Interferon-gamma can be administered prior to infection to effectively suppress the rate, severity, and duration of subsequent bacterial infection, or can be administered subsequent to infection to effectively treat mastitis.
Inventors
- 👤 Lorraine M. Sordillo
- 👤 Lorne A. Babiuk
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 10:10
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/19; A61K38/21; A61K38/217; A61P; A61P15/00; A61P15/14
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
24 words
A method of treating or preventing mastitis in a mammal comprising administering to said mammal by intramammary injection a therapeutically effective amount of interferon.
Claim 2
Independent Claim
24 words
A method of treating or preventing mastitis in a mammal comprising administering to said mammal by intramammary injection a therapeutically effective amount of interferon.
Claim 3
Dependent Claim
10 words
The method of claim 1 wherein said interferon is interferon-gamma.
Claim 4
Dependent Claim
11 words
The method of claim 2 wherein said mammal is a cow.
Claim 5
Dependent Claim
12 words
The method of claim 3 wherein said interferon-gamma is recombinant bovine interferon-gamma.
Claim 6
Independent Claim
26 words
A method for treating or preventing coliform mastitis in a cow comprising administering to said cow by intramammary injection a therapeutically effective amount of bovine interferon-gamma.
Claim 7
Independent Claim
26 words
A method for treating or preventing coliform mastitis in a cow comprising administering to said cow by intramammary injection a therapeutically effective amount of bovine interferon-gamma.
Claim 8
Dependent Claim
14 words
The method of claim 5 wherein said injection is given during the prepartum period.
Claim 9
Dependent Claim
14 words
The method of claim 5 wherein said injection is given during the postpartum period.
Claim 10
Dependent Claim
17 words
The method of claim 5 wherein said interferon-gamma is administered prior to the onset of the infection.
Claim 11
Dependent Claim
15 words
The method of claim 5 wherein said interferon-gamma is administered after the onset of infection.
References Cited (Backward Citations)
US4083959A
Cited
EP0242233A2
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-06-23 | 1995-12-23 | 1996-06-23 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-06-23 | 1999-12-23 | 2000-06-23 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-06-23 | 2003-12-23 | 2004-06-23 | $7700.00 | Window Closed / Lapsed |